GH Research (GHRS) Stock Insights
GHRS$21.55+0.84 +4.06%
$1.48B
Market Cap
-20.71
P/E
—
Forward P/E
67
Score
GH Research (GHRS) Stock Insights
GHRS price $21.55 +0.84 +4.06%
- Ticker
- GHRS
- Price
- $21.55
- Change
- +0.84 +4.06%
- Market cap ?
- $1.48B
- P/E ?
- -20.71
- Dividend yield ?
- 0.00%
- Beta ?
- 1.32
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 67
- Value
- 49
- Quality
- 52
- Growth
- 100
Stocklytics score rationale: value 49, quality 52, growth 100.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has…
Insights · Dividends · Forecast · Financials · Learn